LUMIPORE
LIVE

Serial Number

79366928

Owner

Trince, besloten vennootschap

Attorney

Clifford D Hyra

Filing Date

Feb 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LUMIPORE Trademark

Serial Number: 79366928 • Registration: 7554064

LUMIPORE is a trademark filed by Trince, besloten vennootschap on February 14, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Trince, besloten vennootschap (3 trademarks)

Ottergemsesteenweg-Zuid 731

Entity Type: 99

Trademark Details

Filing Date

February 14, 2023

Registration Date

November 5, 2024

Published for Opposition

August 20, 2024

Goods & Services

Scientific apparatus and instruments for cell modification, namely, transfection devices; scientific apparatus and instruments for scientific research and development, namely, transfection devices for cell modification; scientific apparatus and instruments for scientific research and development, namely, devices for transfection of cells for clinical research and medical research; Scientific apparatus and instruments for use in cell therapy, stem cell therapy, tissue engineering and regenerative medicine, namely, devices for the ablation and killing of cells; laboratory instruments for use in immunotherapy and cancer treatment, namely, transfection devices; laboratory instruments for use in tissue engineering and regenerative medicine, namely, devices for transfection, cell and tissue ablation and cell killing; laboratory instruments for the development of gene modified cell therapies, namely, transfection devices; laboratory equipment for modification of cells for research related to the treatment of diseases, namely, devices for transfection, cell ablation and cell killing; equipment for cell manipulation, namely, devices for transfection, cell ablation and cell killing

Medical devices, namely, transfection devices used for cell therapy treatments; Medical devices, namely, instruments used for immunotherapy treatments and for modifying cells for the treatment of cancer and other diseases and medical conditions related to tissue engineering and regenerative medicine namely, devices for transfection, cell ablation and cell killing; apparatus for the regeneration of stem cells and tissues for medical purpose; medical apparatus and instruments for use in cell therapy, stem cell therapy, tissue engineering and regenerative medicine, namely, devices for transfection, cell ablation and cell killing; unfilled cartridges for cell transfection, cell ablation and cell killing for medical diagnostic purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 7, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 7, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 20, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 4, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 4, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 9, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 1, 2024 GNFN
FINAL REFUSAL E-MAILED
May 1, 2024 GNFR
FINAL REFUSAL WRITTEN
May 1, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 21, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 21, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 21, 2023 COAR
REFUSAL PROCESSED BY IB
Dec 12, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 21, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 21, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 17, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2023 NREP
APPLICATION FILING RECEIPT MAILED
Apr 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 6, 2023 REPR